Sign Up to like & get
recommendations!
0
Published in 2022 at "Medicine"
DOI: 10.1097/md.0000000000031757
Abstract: Rationale: Tofacitinib is an orally administered selective Janus kinase inhibitor. Its efficacy and safety in adults with moderately to severely active ulcerative colitis (UC) have been evaluated in clinical trials; however, its efficacy in pediatric…
read more here.
Keywords:
refractory;
treated tofacitinib;
successfully treated;
colitis ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2019-eular.5986
Abstract: Background: Tofacitinib (TF) is an oral Janus Kinase inhibitor for the treatment of rheumatoid arthritis (RA). Objectives: To evaluate the one-year effectiveness of tofacitinib as first-line therapy in RA conventional synthetic (cs) DMARDs non-responders. Methods:…
read more here.
Keywords:
none declared;
tofacitinib oral;
treatment;
treated tofacitinib ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2023 at "Cutis"
DOI: 10.12788/cutis.0717
Abstract: Lichen planus is a chronic inflammatory immune disorder that most commonly affects the skin and mucous membranes. Esophageal lichen planus (ELP) is a frequently misdiagnosed and poorly understood form of lichen planus that can be…
read more here.
Keywords:
esophageal lichen;
treated tofacitinib;
planus;
lichen planus ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "International Journal of Trichology"
DOI: 10.4103/ijt.ijt_15_22
Abstract: Tofacitinib has been reported to activity in the recovery of alopecia areata (AA) in several reports, mainly from Western countries. We report the case of a young Indian boy with resistant AA who was treated…
read more here.
Keywords:
alopecia areata;
case;
treated tofacitinib;
recovery resistant ... See more keywords